🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Although multiple studies have suggested that treatment with ranibizumab is...
Status
Completed
Location
Retina Associates
Start Date
2012-08
Trial ID
NCT01627249
A 2-year phase 3, multicentre, randomised, parallel-group, sham-controlled,...
Status
Terminated
Location
COAST Investigational Site
Start Date
2021-03-12
Trial ID
NCT04757636
Treatments Being Tested
EYE-RES-104 is a randomized, dose-masked study of intravitreal EYE103 in pa...
Status
Recruiting
Location
Scottsdale, Arizona
Start Date
2025-09-12
Trial ID
NCT07205887
Treatments Being Tested
The purpose of this clinical study is to evaluate the efficacy and safety o...
Status
Terminated
Location
Kanghong Investigative Site
Start Date
2018-09-25
Trial ID
NCT03577899
The purpose of this study is to evaluate the safety and efficacy of single ...
Status
Completed
Location
Retinal Consultants of Arizona
Start Date
2017-08-29
Trial ID
NCT03249740
Treatments Being Tested
The goal of this clinical trial is to to evaluate the clinical outcomes fol...
Status
Recruiting
Location
Baghdad Medical City Complex
Start Date
2025-02-20
Trial ID
NCT06850571
Treatments Being Tested
This study assessed systemic vascular endothelial growth factor (VEGF) leve...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-04
Trial ID
NCT01988662
Treatments Being Tested
The purpose of this clinical study is to evaluate the efficacy and safety o...
Status
Terminated
Location
Kanghong Investigative Site
Start Date
2018-12-21
Trial ID
NCT03630952
This is a single patient investigative treatment study. The patient was dia...
Status
No Longer Available
Location
Vitreous Retina Macula Consultants of New York
Start Date
TBD
Trial ID
NCT01714115
Treatments Being Tested
This study is designed to compare the post injection inflammation and pain ...
Status
Completed
Location
Sierra Eye Associates
Start Date
2015-01
Trial ID
NCT02363621
Treatments Being Tested